|
|
|
27.02.26 - 06:15
|
Research: M Stanley's H-shr Focus List (Table) (AAStocks)
|
|
|
Stocks | Potential Upside from Target PricesAlibaba (BABA.US) | 17.8%CHALCO (601600.SH) | +20.7%CATL (300750.SZ) | 33.3%DUALITYBIO-B (09606.HK) | 41.8%ESPRESSIF (688018.SH)| 30.7%HKEX (00388.HK) | 22%HKT-SS (06823.HK) | 7.1%NARI (600406.SH) | 0.9%PING AN (02318.HK) | 22.6%INOVANCE TECH (300124.SZ) | 25.7%SINOMA SCI & TECH (0......
|
|
|
|
|
26.02.26 - 13:03
|
Zai Lab Announces Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates (Business Wire)
|
|
|
– Total revenues grew 17% y-o-y to $127.6 million for the fourth quarter of 2025 and 15% y-o-y to $460.2 million for the full-year 2025
– Zocilurtatug pelitecan (zoci) on track to become Zai Lab's first global oncology launch, with three registration-enabling studies across 2L+ SCLC, 1L SCLC, and extrapulmonary NECs by the end of 2026
– Advancing a differentiated global pipeline, including ZL-1503 (IL-13/IL-31Rα), ZL-6201 (LRRC15 ADC), ZL-1222 (PD-1/IL-12) and ZL-1311 (MUC17/CD3 TCE)
– Key regional programs continue to advance, with KarXT approved in China and commercial launch preparations underway; pivotal data readouts for povetacicept in IgAN and elegrobart in TED expected in 2026
Conference call and webcast today, February 26, 2026, at 8:00 a.m. ET (9:00 p.m. HKT)SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced financial results for the fourth quarter and full-year 2025, along with recent product highlights and corporate updates.
“20...
|
|
|
|
|
|
|
|
|
|
|
16.02.26 - 04:45
|
Research: Nomura Lifts CSPC PHARMA (01093.HK) TP to $12.04, Keeps Buy Rating (AAStocks)
|
|
|
Nomura issued a research report expecting that CSPC PHARMA (01093.HK)'s 4Q25 revenue will grow by 20% YoY to RMB7.6 billion, slightly higher than the market consensus of RMB7.4 billion. The broker also anticipated that the sales of finished drugs will ebb by 1% YoY to RMB5 billion, while collaboration revenue will be RMB1.1 ......
|
|
|
|
|
12.02.26 - 09:15
|
Full-day Takeaway: HSI Closes at 27,032, Down 233 pts; HSTI Closes at 5,408, Down 91 pts; MEITUAN Down over 4%; WUXI APPTEC, SHK PPT, SINOPEC CORP, CHINA RES MIXC, HK & CHINA GAS Hit New Highs; Market Turnover Rises (AAStocks)
|
|
|
At close, HSI dropped 233 pts or 0.9% to 27,032. HSTI dropped 91 pts or 1.7% to 5,408. HSCEI fell 93 pts or 1.0% to 9,175. Market turnover reached $238.71 billion.Active Heavyweights:MEITUAN (03690.HK) closed at $84.85, down 4.5%TENCENT (00700.HK) closed at $535.5, down 2.3%XIAOMI (01810.HK) closed at $36.52, down 1.6%BABA (0998......
|
|
|
|
|
12.02.26 - 05:15
|
Midday Takeaway: HSI Closes Midday at 27,023, Down 242 pts; HSTI Closes Midday at 5,407, Down 92 pts; MEITUAN Down over 4%; WUXI APPTEC, WUXI BIO, SHK PPT, SINOPEC CORP, HK & CHINA GAS Hit New Highs (AAStocks)
|
|
|
At midday close, HSI dropped 242 pts or 0.9% to 27,023. HSTI dropped 92 pts or 1.7% to 5,407. HSCEI fell 89 pts or 1.0% to 9,178.Active Heavyweights:MEITUAN (03690.HK) closed at $85.15, down 4.2%TENCENT (00700.HK) closed at $533.5, down 2.6%BABA (09988.HK) closed at $156.7, down 2.1%XIAOMI (01810.HK) closed at $36.76, down 0.9%H......
|
|
|
11.02.26 - 08:30
|
Fosun Health to build first overseas hospitals in Indonesia amid Chinese ′go global′ push (SCMP)
|
|
|
Fosun Health Group, a subsidiary of Fosun Pharmaceutical, said it plans to build its first overseas hospitals in Indonesia amid a push by Chinese healthcare companies to expand abroad.
The announcement underscores Indonesia's appeal – home to the world's fourth-largest population of 287 million – as Beijing encourages its healthcare sector to “go global”.
Fosun planned to establish “several hospitals” in Indonesia, CEO Frank Hu Hang told delegates at the South China Morning Post's China......
|
|
|
10.02.26 - 14:36
|
Zai Lab to Announce Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates on February 26, 2026 (Business Wire)
|
|
|
- Company to host conference call and webcast on February 26, 2026, at 8:00 a.m. ET (9:00 p.m. HKT)SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that it will report its fourth quarter and full year 2025 financial results and provide recent corporate updates on February 26, 2026, before the opening of U.S. equity markets. The announcement will be followed by a conference call and webcast at 8:00 a.m. ET (9:00 p.m. HKT).
Conference Call and Webcast Information
The live webcast can be accessed by visiting the Company's website at http://ir.zailaboratory.com. Participants must register in advance of the conference call.
Details are as follows:
Registration link for webcast (preferred): https://edge.media-server.com/mmc/p/ftt8dzjp
Registration link for dial-in: https://register-conf.media-server.com/register/BI3888301d591947ae8d0ccb041164c8e6
All participants must use the link provided above to complete the online registration process in advance of th...
|
|
|
10.02.26 - 09:15
|
Full-day Takeaway: HSI Closes at 27,183, Up 155 pts; HSTI Closes at 5,451, Up 33 pts; CSPC PHARMA Up over 5%; ZTO EXPRESS-W, WH GROUP, BOC HONG KONG, WHARF REIC, HANG LUNG PPT Hit New Highs; Market Turnover Rises (AAStocks)
|
|
|
At close, HSI rose 155 pts or 0.6% to 27,183. HSTI rose 33 pts or 0.6% to 5,451. HSCEI gained 74 pts or 0.8% to 9,242. Market turnover reached $234.04 billion.Active Heavyweights:MEITUAN (03690.HK) closed at $88.8, down 2.5%BABA (09988.HK) closed at $160.5, up 1.6%TENCENT (00700.HK) closed at $551, down 1.6%XIAOMI (01810.HK) clo......
|
|
|
10.02.26 - 04:00
|
Hong Kong stocks extend bounce-back from tech turbulence as risk sentiment returns (SCMP)
|
|
|
Hong Kong stocks gained, extending a rebound from a sell-off in technology companies, as traders returned to the risk-on mode on bets that the tumult has run its course.
The Hang Seng Index rose 0.9 per cent to 27,258.08 as of 10.37am local time. The Hang Seng Tech Index climbed 1.1 per cent. On the mainland, the CSI 300 Index and the Shanghai Composite Index both added 0.1 per cent.
CSPC Pharmaceutical Group rallied 5.5 per cent to HK$10.32, and biotech firm Innovent Biologics gained 5.3 per......
|
|
|
09.02.26 - 03:12
|
Hong Kong stocks start week strong on sentiment stabilisation, Japan election (SCMP)
|
|
|
Hong Kong stocks rose alongside other markets in Asia, as sentiment towards global risk assets stabilised and the victory of Japan's ruling party in the parliamentary election boosted risk appetite.
The Hang Seng Index added 1.3 per cent to 26,913.07 as of 9.52am local time. The Hang Seng Tech Index gained 1.1 per cent.
On the mainland, the CSI 300 Index climbed 1 per cent and the Shanghai Composite Index rose 0.9 per cent.
Biotech firm Innovent Biologics surged almost 5 per cent to HK$83.25,......
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
